ArticleMaedica2026
Clinical Implications of Low Anion Gap in Critically Ill Patients: Insights from the BOLD Multi-Centre Blood Gas Dataset.
Article in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Low and subnormal anion gap (AG) values are frequently overlooked in clinical practice despite potential diagnostic and prognostic implications. We aimed to characterise the distribution of AG and albumin-corrected anion gap (CAG) in a large multicentre cohort of critically ill patients, quantify the prevalence of low and subnormal values and examine AG behaviour in the presence of clinically significant lactic acidosis. Materials and methods: We performed a retrospective secondary analysis of the publicly available Blood Gas and Oximetry Linked Dataset (BOLD), comprising de-identified records from MIMIC-III, MIMIC-IV and eICU-CRD databases. Anion gap and CAG were calculated, with CAG being adjusted for albumin. Low AG was defined as <6 mmol/L, subnormal as 6-10 mmol/L and elevated as >16 mmol/L. Clinically significant lactic acidosis was defined as lactate >5 mmol/L. Mortality differences were assessed using Pearson's chi-square test. Results: Among 37,763 admissions with available AG data, AG was less than 6 mmol/L in 1.6% of patients and <10 mmol/L in 15.3% of subjects. After albumin correction, CAG was less than 6 mmol/L in 0.5% of patients and <10 mmol/L in 5.8% of subjects. In the subgroup with lactate >5 mmol/L, 19.2% of patients did not have an elevated AG and 8.2% did not exhibit an increased CAG. Among patients with normal or low CAG values, in multivariable logistic regression adjusting for age, pH, albumin, SOFA score and comorbidity index, clinically significant lactic acidosis remained independently associated with mortality [adjusted odds ratio (OR) 3.05, 95% confidence interval (CI) 2.04-4.56]. Conclusions: Low and subnormal AG values are relatively common in critically ill patients even after albumin correction and the causes remain unclear. A substantial proportion of patients with clinically significant lactic acidosis do not exhibit an elevated AG. Clinicians should exercise caution when using AG to categorise metabolic disorders, as high-anion-gap physiology may be masked by an underlying low or subnormal anion gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.